AGL
agilon health Inc
82.40$
-2.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
agilon health Inc (AGL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -57 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26 | -26 | -26 | -26 | -28 | -26 | -9.4 | -4.4 | -13 | -41 | -39 | -19 | -49 | -23 | -60 | 2.6 | -50 | -61 | -21 | -13 | -61 | -48 | -19 | -7.7 | 16 | -32 | -35 | -18 | -21 | 24 | -57 | -72 | |
| 10 | 10 | 10 | 10 | -26 | 3.4 | 3.5 | 3.5 | 3.8 | 3.5 | 3.6 | 3.9 | 3.6 | 3.4 | 3.0 | 3.5 | 3.9 | 4.2 | 3.0 | 5.3 | 5.1 | 5.8 | 5.9 | 6.2 | 6.5 | 6.9 | 7.3 | 7.4 | 7.0 | 6.8 | 6.9 | 28 | |
| – | – | – | – | 0.9 | 1.1 | 2.2 | 1.6 | 1.8 | 1.5 | 275 | 12 | 4.4 | 4.0 | 6.6 | 7.9 | 10.0 | 14 | 19 | 21 | 16 | 17 | 18 | 13 | 2.3 | 17 | 15 | 7.5 | 9.5 | 6.3 | 24 | 47 | |
| – | – | – | – | 1.9 | 1.9 | 1.7 | – | 4.4 | 4.4 | 273 | 10 | 13 | 2.5 | 3.7 | 13 | 1.4 | 11 | 11 | 6.8 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 8.3 | 8.3 | 8.3 | -4.6 | 25 | -15 | -6.5 | 2.5 | 26 | -34 | -17 | 2.6 | -7.4 | -30 | -46 | 17 | 0.2 | -91 | -20 | 6.3 | 96 | -63 | -4.0 | 67 | 106 | -39 | 53 | 93 | 83 | -8.4 | -114 | 53 | |
| 1.0 | 1.0 | 1.0 | 1.0 | 0.7 | 0.4 | 0.9 | 0.3 | 0.6 | 4.2 | 0.5 | 5.3 | 3.5 | 5.0 | 16 | 3.7 | 8.3 | 3.7 | 4.1 | 5.8 | 15 | 15 | 9.8 | 14 | 12 | 11 | 3.3 | 17 | 17 | 3.1 | 3.4 | 40 | |
| – | – | – | – | -1.0 | 0.3 | -2.7 | 1.1 | 23 | -9.1 | -67 | -12 | -2.6 | -8.9 | -297 | -131 | -8.0 | -51 | 20 | -11 | -2.2 | 51 | 18 | 47 | 24 | -23 | 70 | 19 | 23 | 19 | 20 | 80 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 200 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -1.7 | -1.7 | -1.7 | -6.7 | 0.0 | 0.2 | 1,171 | 1,173 | 16 | 15 | 5.6 | 10 | 2.4 | 9.6 | -200 | -189 | 0.8 | – | -0.5 | 0.5 | 1.2 | -0.2 | -2.6 | -0.2 | 0.0 | 0.0 | 0.0 | -0.3 | |
| – | – | – | – | -0.8 | -0.8 | -0.8 | – | 31 | 31 | -50 | 0.0 | -6.1 | -1.3 | -1.3 | -1.3 | -1.3 | -1.3 | -1.3 | -1.3 | – | – | – | -1.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.5 | 0.0 | -3.5 | |
| 44 | 44 | 44 | 44 | 104 | 27 | 4.2 | -6.1 | -0.8 | 30 | 1,113 | 0.9 | 10 | 14 | 4.3 | 9.1 | 1.1 | 8.3 | -202 | 1.4 | -0.8 | 0.6 | -1.7 | -1.4 | 0.0 | -0.2 | -2.6 | -0.2 | 0.0 | -5.1 | 4.6 | -0.8 | |
| 17 | 17 | 17 | 17 | 75 | 1.6 | -7.9 | -9.4 | 9.2 | -20 | 1,006 | -30 | -41 | -19 | -353 | -119 | -57 | -103 | -203 | -23 | -64 | 4.2 | -2.2 | 37 | 40 | -55 | 33 | 0.3 | 2.0 | 38 | -33 | 7.4 | |
| -27 | -27 | -27 | -27 | -29 | -27 | -10 | -4.7 | -14 | -45 | -40 | -24 | -52 | -28 | -76 | -1.0 | -58 | -65 | -25 | -19 | -77 | -62 | -28 | 6.7 | 4.0 | -43 | -38 | -35 | -38 | 21 | -61 | -112 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.